Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 645762, 10 pages
http://dx.doi.org/10.1155/2014/645762
Research Article

A-FABP Concentration Is More Strongly Associated with Cardiometabolic Risk Factors and the Occurrence of Metabolic Syndrome in Premenopausal Than in Postmenopausal Middle-Aged Women

1Department of Laboratory Medicine, Collegium Medicum, Nicholas Copernicus University, Sklodowskiej-Curie 9, 85-094 Bydgoszcz, Poland
2Department of Balneology, Collegium Medicum, Nicholas Copernicus University, Leśna 3, 87-720 Ciechocinek, Poland

Received 20 February 2014; Revised 9 May 2014; Accepted 9 May 2014; Published 29 May 2014

Academic Editor: Abel Romero-Corral

Copyright © 2014 Anna Stefanska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kralisch and M. Fasshauer, “Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?” Diabetologia, vol. 56, no. 1, pp. 10–21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Fu, N. Luo, M. F. Lopes-Virella, and W. T. Garvey, “The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages,” Atherosclerosis, vol. 165, no. 2, pp. 259–269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Elmasri, C. Karaaslan, Y. Teper et al., “Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells,” The FASEB Journal, vol. 23, no. 11, pp. 3865–3873, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Peeters, D. P. V. de Kleijn, A. Vink et al., “Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events,” European Heart Journal, vol. 32, no. 14, pp. 1758–1768, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Xu, A. W. K. Tso, B. M. Y. Cheung et al., “Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study,” Circulation, vol. 115, no. 12, pp. 1537–1543, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. von Eynatten, L. P. Breitling, M. Roos, M. Baumann, D. Rothenbacher, and H. Brenner, “Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2327–2335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Baar, C. S. Dingfelder, L. A. Smith et al., “Investigation of in vivo fatty acid metabolism in AFABP/aP2-/- mice,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 1, pp. E187–E193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Jin, D. Peng, S. Yuan et al., “Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio,” Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1761–1765, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. D. C. Y. Yeung, A. Xu, C. W. S. Cheung et al., “Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 8, pp. 1796–1802, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. D. Harlow, M. Gass, J. E. Hall et al., “Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1159–1168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. K. G. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. “2013 Prevention Guidelines Tools—CV risk calculator,” http://my.americanheart.org/professional/StatementsGuidelines/PreventionGuidelines/Prevention-Guidelines_UCM_457698_SubHomePage.jsp.
  13. National Cholesterol Education Program (NCEP) and Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), “Third report of the National Cholesterol Education Program (NCEP) National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report,” Circulation, vol. 106, no. 25, pp. 3143–3421, 2002. View at Google Scholar
  14. C. Maruyama, K. Imamura, and T. Teramoto, “Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia,” Journal of Atherosclerosis and Thrombosis, vol. 10, no. 3, pp. 186–191, 2003. View at Google Scholar · View at Scopus
  15. G. L. Myers, R. H. M. Christenson, M. Cushman et al., “National academy of clinical biochemistry laboratory medicine practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease,” Clinical Chemistry, vol. 55, no. 2, pp. 378–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Szurkowska, K. Szafraniec, A. Gilis-Januszewska, Z. Szybiński, and B. Huszno, “Insulin resistance indices in population-based study and their predictive value in defining metabolic syndrome,” Przegla¿d Epidemiologiczny, vol. 59, no. 3, pp. 743–751, 2005. View at Google Scholar · View at Scopus
  17. D. Stejskal and M. Karpisek, “Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?” European Journal of Clinical Investigation, vol. 36, no. 9, pp. 621–625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Stefanska, G. Sypniewska, B. Blaszkiewicz, I. Ponikowska, and M. Cwiklinska-Jurkowska, “Comparison between C-reactive protein and adipocyte fatty acid-binding protein as a component of metabolic syndrome in middle-aged women,” Clinical Biochemistry, vol. 44, no. 4, pp. 304–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Xu, Y. Wang, J. Y. Xu et al., “Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome,” Clinical Chemistry, vol. 52, no. 3, pp. 405–413, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. W. S. Chow, A. W. Tso, A. Xu et al., “Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study,” Journal of the American Heart Association, vol. 2, no. 1, Article ID e004176, 2013. View at Google Scholar
  21. A. Cabré, I. Lázaro, J. Girona et al., “Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients,” Atherosclerosis, vol. 195, no. 1, pp. e150–e158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Ota, M. Furuhashi, S. Ishimura et al., “Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation,” American Journal of Hypertension, vol. 25, no. 10, pp. 1124–1130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. A. W. K. Tso, A. Xu, P. C. Sham et al., “Serum adipocyte fatty acid-binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort,” Diabetes Care, vol. 30, no. 10, pp. 2667–2672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. K. Hee, J. Park, Y. R. So, and K. I. M. Jongoh, “The effect of menopause on the metabolic syndrome among Korean wwomen: the Korean National Health and Nutrition Examination Survey, 2001,” Diabetes Care, vol. 30, no. 3, pp. 701–706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Marjani and S. Moghasemi, “The metabolic syndrome among postmenopausal women in Gorgan,” International Journal of Endocrinology, vol. 2012, Article ID 953627, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. V. R. Mesch, L. E. Boero, N. O. Siseles et al., “Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status,” Climacteric, vol. 9, no. 1, pp. 40–48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. G. A. Woodard, M. M. Brooks, E. Barinas-Mitchell, R. H. MacKey, K. A. Matthews, and K. Sutton-Tyrrell, “Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women,” Menopause, vol. 18, no. 4, pp. 376–384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Mankowska-Cyl, M. Krintus, P. Rajewski, and G. Sypniewska, “A-FABP and its association with atherogenic risk profile and insulin resistance in young overweight and obese women,” Biomarkers in Medicine, vol. 7, no. 5, pp. 723–730, 2013. View at Google Scholar
  29. Y. Bao, Z. Lu, M. Zhou et al., “Serum levels of Adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women,” PLoS ONE, vol. 6, no. 4, Article ID e19115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Henneman, A. C. J. W. Janssens, M. C. Zillikens et al., “Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome,” Journal of Internal Medicine, vol. 267, no. 4, pp. 402–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. J. Toth, A. Tchernof, C. K. Sites, and E. T. Poehlman, “Effect of menopausal status on body composition and abdominal fat distribution,” International Journal of Obesity, vol. 24, no. 2, pp. 226–231, 2000. View at Google Scholar · View at Scopus
  32. K. Milner, D. van der Poorten, A. Xu et al., “Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease,” Hepatology, vol. 49, no. 6, pp. 1926–1934, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. L. Kuk, S. Lee, S. B. Heymsfield, and R. Ross, “Waist circumference and abdominal adipose tissue distribution: influence of age and sex,” American Journal of Clinical Nutrition, vol. 81, no. 6, pp. 1330–1334, 2005. View at Google Scholar · View at Scopus
  34. M. Zamboni, F. Armellini, M. P. Milani et al., “Body fat distribution in pre- and post-menopausal women metabolic and anthropometric variables and their inter-relationships,” International Journal of Obesity, vol. 16, no. 7, pp. 495–504, 1992. View at Google Scholar · View at Scopus
  35. H. Yamatani, K. Takahashi, T. Yoshida, T. Soga, and H. Kurachi, “Differences in the fatty acid metabolism of visceral adipose tissue in postmenopausal women,” Menopause, vol. 21, no. 2, pp. 170–176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Hayashi, E. J. Boyko, M. J. McNeely, D. L. Leonetti, S. E. Kahn, and W. Y. Fujimoto, “Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans,” Diabetes, vol. 57, no. 5, pp. 1269–1275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Sandeep, K. Gokulakrishnan, K. Velmurugan, M. Deepa, and V. Mohan, “Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic south Indians,” Indian Journal of Medical Research, vol. 131, no. 5, pp. 629–635, 2010. View at Google Scholar · View at Scopus
  38. M. Mölig, M. O. Weickert, E. Ghadamgadai et al., “Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women,” European Journal of Endocrinology, vol. 157, no. 2, pp. 195–200, 2007. View at Publisher · View at Google Scholar · View at Scopus